drugset
drugset / Trial / NCT02670785

A Safety and Efficacy Study of Estradiol Vaginal Capsule in Postmenopausal Women With Vulvovaginal Atrophy

NCT02670785 ↗

Phase 2 Completed 203 enrolled Warner Chilcott
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will access the safety and efficacy of three doses of estradiol vaginal capsules in postmenopausal women with vulvovaginal atrophy.

Timeline

Start
2016-02-15
Primary completion
2016-11-14
Completion
2016-11-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Estradiol Other / unclassified 0.003 mg Other
Subject Estradiol Other / unclassified 0.01 mg Other
Subject Estradiol Other / unclassified 0.02 mg Other

Indications

postmenopausal atrophic vaginitis